Skip to main content

MannKind Corporation (MNKD) Stock

MannKind Corporation Stock Details, Movements and Public Alerts

Stock Details

MannKind Corporation (MNKD), a prominent company in the healthcare sector within the biotechnology industry, is based in United States and primarily trades on the NGM.Currently, the stock is trading at $5.78. Over the past 52 weeks, it has ranged between $3.38 and $6.51. This places the current price at 88.8% of its 52-week high and 71.0% above its 52-week low. Recent trading volume was recorded at 3,011,659. The 14-day Relative Strength Index (RSI) stands at 53.90, suggesting neutral conditions. The stock is currently trading above its 50-day moving average of $5.53 by 4.52%. Similarly, it is above its 200-day moving average of $4.78 by 20.92%. The MACD histogram is -0.01, indicating bearish momentum (MACD Line: 0.14, Signal Line: 0.14).

52-Week Range

$6.51 - $3.38

-11.21% from high · +71.01% from low

Avg Daily Volume

3,377,653

20-day average

100-day avg: 4,323,182

Fundamentals

Valuation Metrics

P/E Ratio (TTM)

57.80

Above market average

Forward P/E

39.41

Earnings expected to grow

EV/EBITDA

20.54

EPS (TTM)

$0.10

Price to Sales

5.66

Beta

0.76

Less volatile than market

Q:How is MNKD valued relative to its earnings and growth?
MannKind Corporation trades at a P/E ratio of 57.80, which is above the market average of approximately 20. This premium valuation suggests investors expect above-average growth or the company has competitive advantages justifying the higher multiple. Looking ahead, the forward P/E of 39.41 is lower than the current P/E, indicating analysts expect earnings to grow over the next year.
Q:What is MNKD's risk profile compared to the market?
With a beta of 0.76, MannKind Corporation is less volatile than the overall market. This means when the market moves up or down by 10%, this stock typically moves less than 10% in the same direction. Lower beta stocks are often preferred by conservative investors seeking stability.

Performance & Growth

Profit Margin

9.32%

Operating Margin

22.86%

EBITDA

$84.72M

Return on Assets

9.95%

Revenue Growth (YoY)

17.20%

Earnings Growth (YoY)

-34.90%

Q:How profitable and efficient is MNKD's business model?
MannKind Corporation achieves a profit margin of 9.32%, meaning it retains $9.32 from every $100 in revenue after all expenses. This represents a solid margin typical of well-run businesses, showing the company can effectively balance revenue generation with cost control. The operating margin of 22.86% reveals how efficiently the company runs its core business operations before interest and taxes.
Q:What are MNKD's recent growth trends?
MannKind Corporation's revenue grew by 17.20% year-over-year, showing steady progress in growing the business. This positive trajectory indicates the company maintains competitive positioning in its markets. Earnings decreased by 34.90% year-over-year, reflecting the bottom-line impact of business performance. These growth metrics should be evaluated against Biotechnology industry averages for proper context.

Company Size & Market

Market Cap

$1.8B

Revenue (TTM)

$313.79M

Revenue/Share (TTM)

$1.05

Shares Outstanding

307.07M

Book Value/Share

-$0.15

Asset Type

EQUITY

Q:What is MNKD's market capitalization and position?
MannKind Corporation has a market capitalization of $1.8B, classifying it as a small-cap stock (under $2B). Small-caps offer significant growth potential but come with higher volatility and risk. They can be more sensitive to economic conditions but may provide outsized returns if successful. With 307.07M shares outstanding, the company's ownership is relatively concentrated. As a participant in the Biotechnology industry, it competes with other firms in this sector.
Q:How does MNKD's price compare to its book value?
MannKind Corporation's book value per share is -$0.15, while the current stock price is $5.78, resulting in a price-to-book (P/B) ratio of -39.86. Trading below book value can indicate the market perceives challenges ahead, or it might represent a value opportunity if the assets are quality and earnings can recover. Value investors often screen for P/B ratios below 1.0. As EQUITY, this represents a specific type of security.

Analyst Ratings

Analyst Target Price

$9.61

66.28% upside potential

Analyst Recommendations

Strong Buy

1

Buy

8

Hold

0

Sell

0

Strong Sell

0

Q:How reliable are analyst predictions for MNKD?
9 analysts cover MNKD with 100% recommending buy/strong buy ratings. Analyst predictions have mixed reliability - studies show consensus rarely beats market returns consistently. The strong bullish consensus may already be priced in. The consensus target of $9.61 implies 66.3% upside, but targets are often adjusted to follow price moves rather than predict them.
Q:What is the Wall Street consensus on MNKD?
Current analyst recommendations:1 Strong Buy, 8 Buy, 000The bullish tilt suggests optimism about future prospects, though investors should conduct independent research.Remember that analyst opinions often lag price movements and can be influenced by investment banking relationships.

Fundamentals last updated: Feb 8, 2026, 02:30 AM

Technical Indicators

RSI (14-day)

53.90

Neutral

50-Day Moving Average

$5.53

4.52% above MA-50

200-Day Moving Average

$4.78

20.92% above MA-200

MACD Line

0.14

MACD Signal

0.14

MACD Histogram

-0.01

Bearish

Q:What does MNKD's RSI value tell investors?
The RSI (Relative Strength Index) for MNKD is currently 53.90, indicating the stock is in neutral territory (40-60 range). Neither buyers nor sellers have clear control, suggesting consolidation or balanced market forces. Combined with the price being above the 50-day moving average, this confirms bullish conditions.
Q:How should traders interpret MNKD's MACD and moving average crossovers?
MACD analysis shows the MACD line at 0.14 below the signal line at 0.14, with histogram at -0.01. This bearish crossover indicates downward pressure. The narrow histogram suggests a potential trend change ahead. The 50-day MA ($5.53) is above the 200-day MA ($4.78), forming a golden cross pattern that typically signals a long-term uptrend. Price is currently above both MAs, confirming strength.

Indicators last updated: Dec 29, 2025, 12:58 AM

Active Alerts

No active alerts for this stock.

Be the first to set up an alert for MNKD and get notified when the price changes.

Stay Ahead of the Market with MannKind Corporation Alerts

Set up price alerts for MannKind Corporation and get notified instantly when the price hits your target. Never miss an important price movement again.